Clinical Trial Detail

NCT ID NCT01111058
Title Everolimus Versus Placebo in Head and Neck Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Chicago
Indications

head and neck squamous cell carcinoma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.